Charles River Laboratories International, Inc. (CRL) stock analysis
CRL · Charles River Laboratories International, Inc.
Latest recorded price: USD 335.63
Sector and industry: Healthcare · Diagnostics & Research
A reliable intrinsic value could not be calculated for CRL; the assessment relies on sector multiple comparisons. Fiscal 2025 figures: revenue growth 0.3%, free cash flow margin 12.9%, ROIC 0.4%. The model flags 1 risk signal for this company (1 high severity).
Similar companies in Healthcare
- Castle Biosciences, Inc. (CSTL)
- Quest Diagnostics Incorporated Common Stock (DGX)
- Danaher Corporation Common Stock (DHR)
- Guardant Health, Inc. (GH)
- IDEXX Laboratories, Inc. - Common Stock (IDXX)
- Illumina, Inc. - Common Stock (ILMN)
- IQVIA Holdings, Inc. Common Stock (IQV)
- Labcorp Holdings Inc. Common Stock (LH)